Predicting Breast Cancer Endocrine Responsiveness Using Molecular Imaging
{{output}}
The estrogen receptor (ER) is expressed on the vast majority of newly diagnosed breast cancers, yet not all ER-positive tumors will respond to endocrine therapy. Selecting patients for endocrine therapy can be considered as a series of predictive tests: does t... ...
